United States v. Goodwin

617 F. App'x 12
CourtCourt of Appeals for the First Circuit
DecidedJuly 21, 2015
Docket14-1165
StatusUnpublished
Cited by2 cases

This text of 617 F. App'x 12 (United States v. Goodwin) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Goodwin, 617 F. App'x 12 (1st Cir. 2015).

Opinion

TORRUELLA, Circuit Judge.

Defendant-Appellant Adam Goodwin pled guilty to conspiracy to possess with intent to distribute Oxycodone, and to aiding and abetting the commission of healthcare fraud. He now challenges his 108-months prison sentence on the grounds that: (1) the four-level role enhancement was unsupported by the evidence before the district court; (2) his sentence is unreasonable because of the disparity with other co-defendants; and (3) he is entitled to a reduction from a post-sentencing retroactive change in- the Sentencing Guidelines. Finding no errors, we affirm.

I. Background

Because Goodwin’s conviction is the result of a guilty plea, we glean the facts from the plea colloquy, the Presentence Investigation Report (“PSR”), and .the transcripts of the presentence conference and sentencing hearing. See United States v. Arbour, 559 F.3d 50, 51 (1st Cir.2009) (citing United States v. Graciani, 61 F.3d 70, 72 (1st Cir.1995)). Although Goodwin objected to several sections of the PSR — to which reference is made in this opinion — the facts relevant to our analysis are not in controversy.

Early in 2010, Goodwin became involved in a conspiracy to distribute prescription pain medication, including the controlled substance Oxycodone. The conspiracy had been orchestrated for several years by Dr. John Perry, the owner of Atlantic Foot & Ankle, a podiatry clinic in Portland, Maine. Dr. Perry devised a scheme by which he would issue hundreds of prescriptions for a variety of controlled substances to individuals who had no real medical need. In the process, Dr. Perry fabricated medical charts and patient files that contained false information in an effort to make it appear that those individuals were legitimate patients who required the medication. Goodwin referred to Dr. Perry at least some of these false patients. The prescriptions were then filled at pharmacies throughout southern Maine, and some were paid for through the Maine Care and Medicare health insurance programs. The pills were delivered to third parties who would sell them illegally, and the cash proceeds were in turn delivered to members of the conspiracy, including Goodwin. Goodwin kept part of the proceeds to finance a night club that he planned to open in Westbrook, Maine.

. During Goodwin’s participation in the conspiracy, between February and November 2010, Dr. Perry issued at least 150 prescriptions totaling over 10,000 pills to Goodwin, co-defendant Neil Laverriere, and a group of six other participants. On some occasions, it was Goodwin who was in charge of delivering cash — usually $400.00 — to Dr. Perry in compensation for the prescriptions.

On November 28, 2012, Goodwin was charged with conspiracy to possess with intent to distribute Oxycodone in violation of 21 U.S.C. §§ 841(a)(1) and 846 (“Count 1”), and healthcare fraud in violation of 18 U.S.C. § 1347 (“Count 2”). Goodwin pled guilty to both charges on July 29, 2013.

*14 The PSR recommended a base offense level of thirty two for the drug conspiracy charge and a four-level enhancement for his aggravating role as an “organizer or leader of a criminal activity that involved five or more participants,” pursuant to section 3Bl.l(a) of the United States Sentencing Commission Guidelines Manual (“USSG”). Goodwin documented his objections to this recommendation, asserting that he should not receive a four-level enhancement because “he did not recruit some of the identified individuals; many of those individuals did not play an active role in carrying out the instant offense, and their roles were so modest that they were not charged with committing a crime....”

At the presentence conference, the district judge asked about Goodwin’s objections to the recommendations in the PSR. The defense counsel explained: “[w]e think that the enhancement is too high. We are not saying there shouldn’t be an enhancement, but that enhancement is too high.” The Government argued that it favored the four-level enhancement and the district court responded “It’s your burden,” signaling that the Government would have to prove Goodwin’s status as an organizer or leader of the conspiracy.

During the sentencing hearing, however, when this issue arose, the Government presented no evidence of Goodwin’s participation as an organizer or leader. Yet, the district court still found that the four-level enhancement was justified. It calculated the base offense level for Count 1 at thirty two and added the four levels corresponding to the enhancement, for a total of thirty six. For Count 2, it found a base offense level of six and added the same four-level enhancement, for a total of ten. Because Goodwin accepted responsibility, the district court reduced the thirty six levels for Count 1, for a total offense level of thirty three. Given Goodwin’s Criminal History Category of III, the calculation resulted in an advisory Guidelines range of 168 to 210 months. The district court granted the Government’s request for a twenty-five percent downward departure and additionally issued a downward variance, and sentenced Goodwin to a below-the-range total term of 108-months imprisonment on each of the counts, to be served concurrently.

This appeal followed.

II. Discussion

A. The Four-Level Enhancement for Goodwin’s Aggravating Role

The aggravating role enhancement of § 3Bl.l(a) requires that the district court find that “the defendant was an organizer or leader of a criminal activity that involved five or more participants or was otherwise extensive.” USSG § 3Bl.l(a). That is, the district court must make two separate findings: (1) the scope of the criminal activity involved five or more participants or was otherwise extensive; and (2) the status of the defendant was that of an organizer or a leader of the criminal activity. Arbour, 559 F.3d at 53 (citing United States v. Tejada-Beltrán, 50 F.3d 105, 111 (1st Cir.1995)). These findings are subject to a preponderance of the evidence standard. Id. (citing United States v. Pierre, 484 F.3d 75, 89 (1st Cir.2007)); see also United States v. Carrero-Hernández, 643 F.3d 344, 350-51 (1st Cir.2011).

These scope-and-status determinations supporting the role enhancement are reviewed for clear error. United States v. Martínez-Medina, 279 F.3d 105, 123 (1st Cir.2002) (“We review role-in-the-offense [enhancements] ... for clear error.”); Arbour, 559 F.3d at 53; United States v. Colón-Muñoz, 318 F.3d 348, 364 (1st Cir.2003); see also Tejada-Belrán, 50 F.3d at *15

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
617 F. App'x 12, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-goodwin-ca1-2015.